DOI: 10.4244/EIJV13IZA2

Current trends in coronary interventions: an overview from the EAPCI registries

Emanuele Barbato1,2*, MD, PhD; Dariusz Dudek3, MD, PhD, FESC; Andreas Baumbach4, MD, FESC; Stephan Windecker5, MD, PhD, FESC; Michael Haude6, MD, FESC

The current report provides a six-year overview of trends for coronary interventions from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) registries1. From 2010 to 2015, significant changes in coronary interventions occurred after compelling clinical evidence for practice change became available and subsequent guideline recommendations were published2. The radial artery has become the preferred vascular access, being chosen in two thirds of the procedures (Table 1). The average number of PCI per operator has slightly increased, though complex procedures such as PCI of the left main, chronic total occlusions and with rotational atherectomy have remained unchanged.

Trends in total PCI and primary PCI (pPCI) numbers followed two main patterns: a stable, slow growing pattern in Group A and a pattern of rapid growth in coronary interventions in Group B. This difference in PCI growth was most likely linked to the median number of PCI at the beginning of the observation period: in countries of Group A twice as many PCI and pPCI per million inhabitants were reported in 2010 as compared with countries of Group B (Table 1). Yet, over the subsequent six years, countries of Group B had an exponential growth especially in pPCI (Figure 1). Overall, the monitored countries have reached or come closer to the 600 pPCI per million inhabitants recommended by the Stent for Life initiative3.

Figure 1. Trends in PCI and primary PCI (pPCI) from 2010 to 2015. Upper panels: PCI total and pPCI are expressed as increase versus 2010 per million inhabitants. Lower panel: ratio of pPCI to total PCI. Countries of Group A: Belgium, Denmark, France, Israel, Italy, Poland, Spain, Sweden, Switzerland, UK. Countries of Group B: Egypt, Kazakhstan, Macedonia, Portugal, Serbia.

Strong evidence in favour of the use of drug-eluting stents (DES) has become available both in elective and in acute coronary syndrome patients1. This was associated with a high DES penetration rate (above 70% in most of the countries) with a growth ranging between 20% and 50% (Figure 2). However, reimbursement issues still represented the main obstacle in some countries.

Figure 2. Penetration of drug-eluting stents (DES) in 2015 (bars), and rate of DES adoption (continuous line) from 2010 to 2015 in the 15 countries providing data on DES implantation. DES data unavailable for Turkey.

Finally, despite the lack of reimbursement in many countries, the use of intracoronary physiology techniques doubled from 2010 to 2015, though it still remained lower than 6% and 20% of the total volume of coronary angiography and of PCI, respectively (Figure 3). Given the less strong evidence, a stable and rather low trend in the adoption of intracoronary imaging techniques was observed during the period analysed (Table 1).

Figure 3. Rate of invasive physiologic assessment (IC physiology) overall (black line) and in the individual participating countries (coloured lines). Upper panel: IC physiology corrected by total number of coronary angiographies. Lower panel: IC physiology corrected by total number of PCI (after excluding pPCI).

Despite inherent limitations linked to the heterogeneous data collection, this six-year overview of the EAPCI registries demonstrates a good overall adoption of novel therapies and implementation of guideline recommendations. Budget constraints and limited reimbursement policies still represent the main reasons for the scattered rate of adoption and implementation.

Conflict of interest statement

The authors have no conflicts of interest to declare.


References

Volume 13 Supplement Z
May 15, 2017
Volume 13 Supplement Z
View full issue


Key metrics

Suggested by Cory

10.4244/EIJ-D-16-00870 May 15, 2017
Italy: coronary and structural heart interventions from 2010 to 2015
Berti S et al
free

10.4244/EIJ-D-16-00834 May 15, 2017
Spain: coronary and structural heart interventions from 2010 to 2015
García del Blanco B et al
free

10.4244/EIJ-D-16-00828 May 15, 2017
Switzerland: coronary and structural heart interventions from 2010 to 2015
Rigamonti F et al
free

10.4244/EIJ-D-16-00831 May 15, 2017
Portugal: coronary and structural heart interventions from 2010 to 2015
Teles RC et al
free

10.4244/EIJV7I6A31 Jun 30, 2010
Percutaneous coronary interventions in Europe in 2006
Moschovitis A et al
free

10.4244/EIJ-D-16-00830 May 15, 2017
Sweden: coronary and structural heart interventions from 2010 to 2015
Witt N et al
free

10.4244/EIJ-D-16-00836 May 15, 2017
Poland: coronary and structural heart interventions from 2010 to 2015
Legutko J et al
free

10.4244/EIJV10I9A175 Jan 22, 2015
Standards of care: The EAPCI, guidelines and consensus documents
Windecker S
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved